Lv1
30 积分 2025-03-07 加入
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD
3小时前
待确认
A global view of pulmonary hypertension
1个月前
已完结
Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry
2个月前
已完结
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
4个月前
已完结
Research progress on the pathogenesis of chronic obstructive pulmonary disease combined with pulmonary hypertension
4个月前
已完结
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
4个月前
已完结
Group 3 Pulmonary Hypertension: A Review of Diagnostics and Clinical Trials
5个月前
已完结
Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management
5个月前
已完结
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
5个月前
已完结
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease
5个月前
已完结
皖公网安备34019202002308
